INBX vs CCEC
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
INBX · Inhibrx Biosciences$84.52 ▲ 5.28%
CCEC · Capital Clean Energy Carriers$20.59 ▼ 0.68%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- INBX +7.0%
- CCEC +2.2%
Head to head
| Metric | INBX | CCEC |
|---|---|---|
| Price | $84.52 | $20.59 |
| Change today | ▲ 5.28% | ▼ 0.68% |
| Market cap | $1.24B | $1.24B |
| Return, 3 months | -9.2% | -7.2% |
| Return, year to date | +7.0% | +0.7% |
| Return, 1 year | +4.7% | +1.6% |
| P/E (TTM) | – | 10.1 |
| P/B | -23.5 | 0.8 |
| P/E percentile vs own 5y | 24th | 87th |
| Dividend yield | – | 2.91% |
| Revenue growth (YoY, latest qtr) | -100.0% | +8.5% |
| Net profit growth (YoY) | -27.9% | -3.1% |
| Gross margin | – | 53.9% |
| Operating margin | – | 50.0% |
| Net margin | – | 28.0% |
| Return on equity | -1,773.6% | 7.4% |
| Analyst target vs. price | +215.5% | – |
| Analyst buy share | 100% | – |
| RSI (14) | 47 | 48 |
| 30-day volatility | 104.5% | 70.0% |
| Max drawdown, 1 year | -49.4% | -26.2% |
| Trend read | Leaning bearish | Leaning bearish |
| Analyst consensus | Buy | – |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- CCEC is the largest of the group by market value.
- INBX has returned the most over the past year.
- CCEC is growing revenue fastest.
- CCEC has been the calmest stock over the last 30 days.